Synamics Therapeutics ApS

CVR 44258048 · Private limited company (ApS) · Active · High risk

Synamics Therapeutics ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 3.4% over the next 12 months, which is 2.4 times the average for Danish companies. 3 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -115k and a net result of DKK -588k. CEO: Violet Zahedi.

Bankruptcy risk for Synamics Therapeutics ApS

3.4%
probability of bankruptcy within 12 months
High risk

2.4 × the average (1.41%) · higher risk than 88% of active Danish companies

Lowest riskHighest risk

Increases the risk

Reporting classReporting class B, mikrovirksomhed · bankruptcy rate 23.5%2.7×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Equity ratio-50%–0% · bankruptcy rate 14.8%1.7×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×

Reduces the risk

Capital changes2 · bankruptcy rate 5.2%0.59×
Has a boardYes · bankruptcy rate 6.0%0.68×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×
CEO's other companies1 · bankruptcy rate 7.3%0.83×
Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44258048
Status
Active
Company type
Private limited company (ApS)
Founded
(3 years)
Address
c/o Synamics Therapeutics, Fruebjergvej 3
2100 København Ø
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 51k
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 3
Missing annual reportNo
Negative equityYes
Equity ratio-15.4%
Current ratio14%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address611
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 129kDKK -1.7mDKK -17k
Net profitDKK -588kDKK -1.6mDKK -13k
EquityDKK -115kDKK 473kDKK 27k
Total assetsDKK 748kDKK 3.5mDKK 38k
CashDKK 82kDKK 3.0m–
Short-term debtDKK 859kDKK 3.0m–

Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025181
1 Jan 2024 – 31 Dec 2024192 Late
24 Aug 2023 – 31 Dec 2023145

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOViolet ZahediCurrent
BoardViolet ZahediCurrent
BoardAaron Daniel CaparCurrent
BoardAlbert Jelke KooistraCurrent
BoardPer FalholtCurrent
BoardHelder Takashi Imoto Nakaya
Owner (100%)Synamics Therapeutics Inc.Current
Owner (15%)Albert Jelke Kooistra
Owner (15%)Helder Takashi Imoto Nakaya
Owner (67%)Continuum Holdings Inc.
Owner (33%)Continuum Holdings Inc.
Owner (33%)Xivius LLC
Owner (10%)Steen Riisgaard
Owner (10%)Albert Jelke Kooistra
Owner (10%)LILLE FREDERIKSLUND INVEST ApS
Owner (10%)Helder Takashi Imoto Nakaya
Owner (25%)Continuum Holdings Inc.
Owner (25%)Xivius LLC
Owner (10%)Violhuset ApS
Owner (10%)Lille Frederikslund Tech Invest ApS
Owner (100%)Synamics Therapeutics Inc.
Owner (90%)Synamics Therapeutics Inc.
FounderAlbert Jelke KooistraCurrent
FounderHelder Takashi Imoto NakayaCurrent
FounderContinuum Holdings Inc.Current

The CEOs' other companies

Violet Zahedi – 1 other companies

Address history (2 moves)

c/o Synamics Therapeutics, Fruebjergvej 3, 2100 København Ø
Tuborg Havnepark 18, 2. th, 2900 Hellerup
Dyssegårdsvej 87, 2870 Dyssegård

Other companies at the same address

Similar companies in København

Questions and answers about Synamics Therapeutics ApS

Has Synamics Therapeutics ApS gone bankrupt?

No, Synamics Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Synamics Therapeutics ApS?

Our model estimates a bankruptcy risk of 3.4% over the next 12 months (high risk), which is 2.4 times the average for Danish companies.

Who is the CEO of Synamics Therapeutics ApS?

Violet Zahedi is the CEO of Synamics Therapeutics ApS.

When was Synamics Therapeutics ApS founded?

Synamics Therapeutics ApS was founded on 24 August 2023.

What is the equity of Synamics Therapeutics ApS?

Equity was DKK -115k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.